Hourglass Capital LLC lowered its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 32.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,210 shares of the company's stock after selling 10,800 shares during